⌕
Pacific Biosciences of California · PACB · Nasdaq
Tenet 40 · Weak
Compare
$1.84−6.12%At closeTenet 40 · Weak
$1.84−0.12 (−6.12%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

Pacific Biosciences of California (PACB) Institutional Ownership

13F filers reported holding 42.6% of Pacific Biosciences of California (PACB) shares as of Sep 30, 2026, across 178 filers.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice
Held by 13F filers
42.6%
Sep 30, 2026
13F filers
178
quarter ended Sep 30, 2026
13F value
$315.7M
133.3M shares
Quarter's fund flow
Mild distribution
13 new · 31 closed

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

13F fund flowQuarter ended Sep 30, 2026: more funds trimmed or exited than added or entered, mild distribution (13 new · 54 increased · 38 reduced · 31 closed · 42 unchanged or with no prior quarter on file). Flows at this scale move slowly; treat as context. These positions are 48 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
Basis: shares reported by 178 13F filers for Sep 30, 2026, over shares outstanding implied from the current quote, measured 48 days apart. It measures the ownership we have filings for, not total institutional ownership, and it moves with the share count between filings.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Oct 6, 2026Gibson James R IISee RemarksAcquired · Option exercise500,000$1.18↗
Oct 6, 2026Gibson James R IISee RemarksDisposed · Open-market sale661,815$3.11↗
Oct 6, 2026Gibson James R IISee RemarksDisposed · Option exercise500,000Stock Option (right to buy)—↗
Aug 17, 2026Van Oene MarkSee RemarksDisposed · Open-market sale26,911$1.13↗
Aug 10, 2026Van Oene MarkSee RemarksAcquired · Grant / award489,130—↗
Aug 10, 2026Van Oene MarkSee RemarksAcquired · Grant / award1,967,888Stock Option (right to buy)—↗
Jun 3, 2026MOHR MARSHALLdirectorAcquired · Grant / award223,492Stock Option (right to buy)—↗
Jun 3, 2026Gibson ChristopherdirectorAcquired · Grant / award74,497Stock Option (right to buy)—↗
Jun 3, 2026Smith Christopher MdirectorAcquired · Grant / award223,492Stock Option (right to buy)—↗
Jun 3, 2026Valantine HannahdirectorAcquired · Grant / award223,492Stock Option (right to buy)—↗
Jun 3, 2026LIVINGSTON RANDALL SdirectorAcquired · Grant / award223,492Stock Option (right to buy)—↗
Jun 3, 2026Ericson William W.directorAcquired · Grant / award223,492Stock Option (right to buy)—↗
Jun 3, 2026MILLIGAN JOHN FdirectorAcquired · Grant / award223,492Stock Option (right to buy)—↗
Jun 3, 2026ORDONEZ KATHYdirectorAcquired · Grant / award223,492Stock Option (right to buy)—↗
Apr 8, 2026Gibson ChristopherdirectorAcquired · Grant / award57,473—↗
Apr 8, 2026Gibson ChristopherdirectorAcquired · Grant / award77,842Stock Option (right to buy)—↗
Apr 1, 2026Gibson James R IISee RemarksDisposed · Open-market sale88,185$1.37↗
Mar 3, 2026Gibson ChristopherdirectorAcquired · Grant / award53,913—↗
Mar 3, 2026Gibson ChristopherdirectorAcquired · Grant / award73,087Stock Option (right to buy)—↗
Mar 3, 2026HENRY CHRISTIAN OSee RemarksDisposed · Open-market sale12,497$1.51↗

* Holdings as reported for Sep 30, 2026, 48 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How much of Pacific Biosciences of California do institutions hold?

13F filers reported holding 42.6% of Pacific Biosciences of California's shares as of Sep 30, 2026, across 178 filers.

How many 13F filers hold Pacific Biosciences of California?

Pacific Biosciences of California was held by 178 13F filers as of Sep 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.